China NT Pharma Group Company Limited (HKG:1011)
Hong Kong
· Delayed Price · Currency is HKD 0.670
+0.020 (3.08%)
Apr 29, 2026, 3:38 PM HKT
HKG:1011 Revenue
In the year 2025, China NT Pharma Group Company had annual revenue of 24.16M CNY, down -36.36%. China NT Pharma Group Company had revenue of 12.16M in the half year ending December 31, 2025.
Revenue
24.16M CNY
Revenue Growth
-36.36%
P/S Ratio
23.65
Revenue / Employee
1.15M CNY
Employees
21
Market Cap
635.83M HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Lee's Pharmaceutical Holdings | 1.44B |
| Zhongzhi Pharmaceutical Holdings | 1.93B |
| Pak Fah Yeow International | 214.28M |
| Fusen Pharmaceutical Company | 304.20M |
| Wai Yuen Tong Medicine Holdings | 721.27M |
| Jilin Province Huinan Changlong Bio-pharmacy Company | 1.00B |
| Dawnrays Pharmaceutical (Holdings) | 1.37B |
| Essex Bio-Technology | 1.81B |